Voucher application details focus on AUD as a major driver of the U.S. substance use crisis and the genetic targeting of AD04 ...

Taimei Technology, a leading AI-driven drug clinical development platform, made its first public appearance in South Korea at BioKorea 2026, drawing significant attention with its advanced AI-powered ...

HERVolution Therapeutics, a biotechnology company pioneering human endogenous retrovirus (HERV)-targeting immunotherapies for oncology, metabolic diseases, and longevity, today announced the ...

U.S. academic medical centers risk losing leadership in drug discovery and development as global competition—especially from ...

An FDA initiative to implement real-time clinical trials could dramatically accelerate the pace at which new treatments ...

Thanks to new regulatory frameworks like the Food and Drug Administration’s Breakthrough Therapy designation, drugs are coming to market faster than ever. A 2024 analysis of drugs included in this ...

PALO ALTO, Calif.--(BUSINESS WIRE)--Science Exchange, the leading SaaS provider of supplier orchestration solutions for the life sciences industry, today announced the launch of its Clinical ...

Rare disease research operates under conditions of extreme complexity. These pressures are driving new approaches to evidence ...

Leda Mannent, MD, global project head, Immunology and Inflammation, Sanofi, outlines future steps for the clinical development of rilzabrutinib, as well as promising data to advance to phase 3 studies ...

Phase I/II clinical trial interim results, out to 168 days, from the two RV-001 dosing cohorts with advanced Retinitis ...

Entropy Neurodynamics and LTR Pharma among ASX health companies reporting clinical milestones reached in quarterly results.